168 related articles for article (PubMed ID: 25472493)
1. Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk.
Yamagishi S; Matsui T; Fukami K
Rejuvenation Res; 2015 Feb; 18(1):48-56. PubMed ID: 25472493
[TBL] [Abstract][Full Text] [Related]
2. Role of receptor for advanced glycation end products (RAGE) in liver disease.
Yamagishi S; Matsui T
Eur J Med Res; 2015 Feb; 20(1):15. PubMed ID: 25888859
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression.
Eva TA; Barua N; Chowdhury MM; Yeasmin S; Rakib A; Islam MR; Emran TB; Simal-Gandara J
Crit Rev Food Sci Nutr; 2022; 62(10):2655-2672. PubMed ID: 33307763
[TBL] [Abstract][Full Text] [Related]
4. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.
Yamagishi S; Maeda S; Matsui T; Ueda S; Fukami K; Okuda S
Biochim Biophys Acta; 2012 May; 1820(5):663-71. PubMed ID: 21440603
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
Yamagishi S
Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
Yamagishi S; Fukami K; Matsui T
Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
[TBL] [Abstract][Full Text] [Related]
7. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
Yamagishi S
Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
[TBL] [Abstract][Full Text] [Related]
8. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
Yamagishi S
Rejuvenation Res; 2012 Dec; 15(6):564-72. PubMed ID: 22950433
[TBL] [Abstract][Full Text] [Related]
9. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
Yamagishi S; Matsui T
Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
[TBL] [Abstract][Full Text] [Related]
11. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
Yamagishi S; Taguchi K; Fukami K
Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes.
Yamagishi S; Matsui T; Nakamura K
Med Hypotheses; 2008 Nov; 71(5):749-51. PubMed ID: 18710793
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
[TBL] [Abstract][Full Text] [Related]
14. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
Lalla E; Lamster IB; Schmidt AM
Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
[TBL] [Abstract][Full Text] [Related]
15. [Bone metabolism and cardiovascular function update. Impairment of osteo-vascular interaction by glyco-oxidative stress].
Yamagishi SI
Clin Calcium; 2014 Jul; 24(7):85-91. PubMed ID: 24976060
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
Lalla E; Lamster IB; Stern DM; Schmidt AM
Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
[TBL] [Abstract][Full Text] [Related]
17. A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Matsui T; Inoue H
Med Hypotheses; 2007; 69(2):338-40. PubMed ID: 17329034
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
[TBL] [Abstract][Full Text] [Related]
19. Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.
Matsui T; Oda E; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2015 Jan; 14():1. PubMed ID: 25582325
[TBL] [Abstract][Full Text] [Related]
20. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
Yamagishi SI; Nakamura N; Matsui T
J Diabetes; 2017 Feb; 9(2):141-148. PubMed ID: 27556881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
